‘With this study, we have hope that something is coming’: community members’ perceptions of HIV cure-related research in Durban, South Africa – a qualitative focus group study
Background Developing a cure for HIV remains a global scientific priority. In 2022, the Females Rising through Education, Support and Health (FRESH) cohort launched an HIV cure-related trial involving an analytical treatment interruption (ATI) in Durban, South Africa. Objectives To explore community...
Saved in:
| Main Authors: | Karine Dubé, Deli Mthimkhulu, Wiseman Ngcobo, Deborah Mindry, Luyanda Maphalala, Vanessa Pillay, Whitney Tran, Ana Korolkova, Thumbi Ndung’u, Krista Dong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | HIV Research & Clinical Practice |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/25787489.2023.2243046 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
‘It is scary to pause treatment’: perspectives on HIV cure-related research and analytical treatment interruptions from women diagnosed during acute HIV in Durban, South Africa: Socio-Behavioral research
by: Deli Mthimkhulu, et al.
Published: (2025-12-01) -
Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States
by: Karine Dubé, et al.
Published: (2024-01-01) -
Motivations, acceptability and ethical considerations for interventional HIV cure research at the end of life: perspectives from long-term survivors of HIV in the United States
by: Ali Ahmed, et al.
Published: (2025-08-01) -
Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States
by: Andrea Bilger, et al.
Published: (2023-12-01) -
Antiretroviral therapy initiated during acute infection in women with HIV-1 clade C reduces anti-Tat antibody production and lowers CD8+ T cell activation
by: Thandeka I. Kubheka, et al.
Published: (2025-06-01)